These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 15265397

  • 1. [Submucosal injection of anti-tumor drug on the prevention of Post-TUR-Bt recurrence].
    Chen X, Wang B, Tian HZ, Gao JZ.
    Zhonghua Wai Ke Za Zhi; 2004 May 22; 42(10):580-2. PubMed ID: 15265397
    [Abstract] [Full Text] [Related]

  • 2. [Intravesial instillation of recombination interferon-alpha and pirarubicin in the prophylaxis of local recurrence after resection of the superficial bladder cancer].
    Deng JH, Bai JL, Zhang SS, Ma PC, Wan JH.
    Ai Zheng; 2004 Jul 22; 23(7):839-41. PubMed ID: 15248924
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ, Shen ZJ, Lu J, Jin XD, Chen J, Shi SF.
    Zhonghua Wai Ke Za Zhi; 2005 Nov 15; 43(22):1457-60. PubMed ID: 16318813
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma.
    Li LY, Yang M, Zhang HB, Su XK, Xu WF, Chen Y, Shen ZJ, Gao X.
    BJU Int; 2008 Aug 05; 102(5):566-71. PubMed ID: 18410436
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep 05; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 9. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG.
    J Urol; 2005 Apr 05; 173(4):1163-8. PubMed ID: 15758728
    [Abstract] [Full Text] [Related]

  • 10. Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer.
    Akçetin Z, Todorov J, Tüzel E, Engehausen DG, Krause FS, Sauer R, Schrott KM, Rödel C.
    Anticancer Res; 2005 Apr 05; 25(3A):1623-8. PubMed ID: 16033071
    [Abstract] [Full Text] [Related]

  • 11. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF.
    Urology; 2007 Sep 05; 70(3):482-6. PubMed ID: 17905101
    [Abstract] [Full Text] [Related]

  • 12. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K, Chihara Y, Kondo H, Hirao Y.
    Hinyokika Kiyo; 2006 Jun 05; 52(6):433-8. PubMed ID: 16848356
    [Abstract] [Full Text] [Related]

  • 13. Alpha 2-b interferon and farmarubicin in the prophylaxis of recurrence of superficial transitional cell carcinoma of the urinary bladder.
    Cervenakov I, Szoldova K, Mardiak J, Chovan D, Mala M, Slavov D.
    Bratisl Lek Listy; 2000 Jun 05; 101(6):317-20. PubMed ID: 11039202
    [Abstract] [Full Text] [Related]

  • 14. [Prophylactic effect of UFT on the recurrence of bladder cancer].
    Naito K, Hisazumi H, Saka A, Nakamura T, Kanda S, Mikawa I, Ejiri S, Miyagi T, Katsumi T, Kitagawa K.
    Hinyokika Kiyo; 1990 Apr 05; 36(4):487-94. PubMed ID: 2116083
    [Abstract] [Full Text] [Related]

  • 15. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Herr HW.
    J Urol; 2005 Dec 05; 174(6):2134-7. PubMed ID: 16280743
    [Abstract] [Full Text] [Related]

  • 16. [Serum uptake of doxorubicin intravesically administered soon after transurethral resection of bladder carcinoma].
    Nagakura K, Takao M, Odajima K, Ieda K, Fujioka T, Hayakawa M, Murai M, Nakamura H.
    Hinyokika Kiyo; 1989 Sep 05; 35(9):1509-12. PubMed ID: 2816617
    [Abstract] [Full Text] [Related]

  • 17. [Invasive bladder cancer recurrenced 5 years after complete response status by chemotherapy and radiotherapy: a case report].
    Ito S, Yokomizo S, Imazu T, Sugao H.
    Hinyokika Kiyo; 2005 Nov 05; 51(11):755-7. PubMed ID: 16363709
    [Abstract] [Full Text] [Related]

  • 18. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M, Miyanaga N, Tokuuye K, Saida Y, Ohara K, Sugahara S, Kagei K, Igaki H, Hashimoto T, Hattori K, Shimazui T, Akaza H, Akine Y.
    Int J Radiat Oncol Biol Phys; 2006 Apr 01; 64(5):1371-9. PubMed ID: 16580495
    [Abstract] [Full Text] [Related]

  • 19. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
    Daniltchenko DI, Riedl CR, Sachs MD, Koenig F, Daha KL, Pflueger H, Loening SA, Schnorr D.
    J Urol; 2005 Dec 01; 174(6):2129-33, discussion 2133. PubMed ID: 16280742
    [Abstract] [Full Text] [Related]

  • 20. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT, Yildirim U, Zorlu F, Ozen H.
    J Urol; 2006 May 01; 175(5):1641-4. PubMed ID: 16600720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.